Literature DB >> 1393288

Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro.

P Van den Hooff1, M Galvan.   

Abstract

1. The actions of 5-hydroxytryptamine (5-HT) and some 5-HT1A receptor ligands on neurones in the rat dorso-lateral septal nucleus were recorded in vitro by intracellular recording techniques. 2. In the presence of tetrodotoxin (1 microM) to block any indirect effects, bath application of 5-HT (0.3-30 microM) hyperpolarized the neurones in a concentration-dependent manner and reduced membrane resistance. The hyperpolarization did not exhibit desensitization and was sometimes followed by a small depolarization. 3. The 5-HT1A receptor ligands, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), N,N-dipropyl-5-carboxamidotryptamine (DP-5-CT) and buspirone but not the non-selective 5-HT1 receptor agonist, 1-m-trifluoromethylphenylpiperazine (TFMPP), also hyperpolarized the neurones. 4. 5-HT, 8-OH-DPAT and DP-5-CT appeared to act as full agonists whereas buspirone behaved as a partial agonist. The estimated EC50S were: DP-5-CT 15 nM, 8-OH-DPAT 110 nM, 5-HT 3 microM and buspirone 110 nM. 5. At a concentration of 3 microM, the putative 5-HT1A receptor antagonists, spiperone, methiothepin, NAN-190 (1-(2-methoxyphenyl)-4-[4-(2-pthalimido)butyl]piperazine) and MDL 73005EF (8-[2-(2,3-dihydro-1,4-benzodioxin-2-yl-methylamino)ethyl]-8- azaspiro[4,5]decane-7,9-dione methyl sulphonate), produced a parallel rightward shift in the concentration-response curve to 5-HT with no significant reduction in the maximum response. The estimated pA2 values were: NAN-190 6.79, MDL 73005EF 6.59, spiperone 6.54 and methiothepin 6.17.6. The 5-HT2/5-HTlc receptor antagonist, ketanserin (3 microM) and the 5HT3 receptor antagonist, tropisetron (3 microM) did not antagonize the 5-HT-induced hyperpolarizations; however, ketanserin blocked the depolarization which sometimes followed the hyperpolarization.7. It is concluded that the 5-HT-induced membrane hyperpolarization of rat dorso-lateral septal neurones is mediated by 5-HTA receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393288      PMCID: PMC1907649          DOI: 10.1111/j.1476-5381.1992.tb14431.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  5-Hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones.

Authors:  R A North; N Uchimura
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

2.  Electrophysiology of the 5-HT1A ligand MDL 73005EF in the rat hippocampal slice.

Authors:  P Van den Hooff; M Galvan
Journal:  Eur J Pharmacol       Date:  1991-04-24       Impact factor: 4.432

3.  Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Neuropharmacology       Date:  1988-07       Impact factor: 5.250

4.  8-OH-DPAT is a strong antagonist of 5-HT action in rat hippocampus.

Authors:  A Colino; J V Halliwell
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

5.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat.

Authors:  E C Azmitia; M Segal
Journal:  J Comp Neurol       Date:  1978-06-01       Impact factor: 3.215

6.  Two distinct effects of 5-hydroxytryptamine on single cortical neurons.

Authors:  M F Davies; R A Deisz; D A Prince; S J Peroutka
Journal:  Brain Res       Date:  1987-10-13       Impact factor: 3.252

7.  Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.

Authors:  R Andrade; R A Nicoll
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

8.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

Authors:  C P VanderMaelen; G K Matheson; R C Wilderman; L A Patterson
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

9.  A G protein couples serotonin and GABAB receptors to the same channels in hippocampus.

Authors:  R Andrade; R C Malenka; R A Nicoll
Journal:  Science       Date:  1986-12-05       Impact factor: 47.728

10.  Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.

Authors:  E Meller; M Goldstein; K Bohmaker
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

View more
  9 in total

Review 1.  Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

Authors:  Yukihiro Ohno
Journal:  CNS Neurosci Ther       Date:  2010-11-21       Impact factor: 5.243

2.  Tonic serotonergic input increases the burst firing mode and diminishes the firing rate of reticular thalamic nucleus neurons through 5-HT1A receptors activation in anesthetized rats.

Authors:  Rafael Barrientos; Alberto Alatorre; Aldo Oviedo-Chávez; Alfonso Delgado; Nielsine Nielsen; Enrique Querejeta
Journal:  Exp Brain Res       Date:  2022-03-02       Impact factor: 1.972

3.  Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Authors:  Saki Shimizu; Yukihiro Ohno
Journal:  Aging Dis       Date:  2012-11-29       Impact factor: 6.745

4.  Intraseptal injection of the 5-HT1A/5-HT7 agonist 8-OH-DPAT and working memory in rats.

Authors:  Hélène Jeltsch; Fabrice Bertrand; Rodrigue Galani; Christine Lazarus; Sarah Schimchowitsch; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2004-03-11       Impact factor: 4.530

5.  Differential effects of centrally-active antihypertensives on 5-HT1A receptors in rat dorso-lateral septum, rat hippocampus and guinea-pig hippocampus.

Authors:  D J Leishman; P H Boeijinga; M Galvan
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

Review 6.  The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety.

Authors:  Sayamwong E Hammack; Ji-Dong Guo; Rimi Hazra; Joanna Dabrowska; Karyn M Myers; Donald G Rainnie
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-05-23       Impact factor: 5.067

7.  The modulatory role of the lateral septum on neuroendocrine and behavioral stress responses.

Authors:  Georg M Singewald; Alesja Rjabokon; Nicolas Singewald; Karl Ebner
Journal:  Neuropsychopharmacology       Date:  2010-12-15       Impact factor: 7.853

Review 8.  Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.

Authors:  Xuefei Huang; Jing Yang; Sijin Yang; Shousong Cao; Dalian Qin; Ya Zhou; Xiaoli Li; Yun Ye; Jianming Wu
Journal:  Oncotarget       Date:  2017-10-27

9.  Presynaptic selectivity of a ligand for serotonin 1A receptors revealed by in vivo PET assays of rat brain.

Authors:  Takeaki Saijo; Jun Maeda; Takashi Okauchi; Jun-ichi Maeda; Yasunori Morio; Yasuhiro Kuwahara; Masayuki Suzuki; Nobuharu Goto; Toshimitsu Fukumura; Tetsuya Suhara; Makoto Higuchi
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.